| Literature DB >> 23653175 |
Janet M Wojcicki1, Jillian D Geissler, Christina W Stokes, Melvin B Heyman, C T Tran.
Abstract
The RESPeRATE device was tested for feasibility of use in a population of overweight and obese children and adolescents (n = 10) in San Francisco, CA. After a 2-week and then a 2-month period, participants were interviewed on their frequency of use and attitudes towards the device. A high percentage stated that they enjoyed using the device at 2 months (90%) and 80% stated that they would recommend use to a friend or relative. Future studies are needed to assess the efficacy of the RESPeRATE device in lowering blood pressure and helping with weight loss/weight management in obese and overweight children.Entities:
Mesh：
Year: 2013 PMID： 23653175 PMCID： PMC4456090 DOI： 10.1007/s40292-013-0014-3
Source DB: PubMed Journal: High Blood Press Cardiovasc Prev ISSN： 1120-9879